Champions Oncology, Inc. (CSBR) is a publicly traded Healthcare sector company. As of May 21, 2026, CSBR trades at $5.99 with a market cap of $84.29M and a P/E ratio of 17.65. CSBR moved +0.00% today. Year to date, CSBR is -9.16%; over the trailing twelve months it is +2.20%. Its 52-week range spans $3.75 to $11.99. Rallies surfaces CSBR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
CSBR financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. CSBR recently traded at $5.99. Market cap is $84.29M. P/E ratio is 17.65. Revenue is $56.94M.
| Metric | Value |
|---|---|
| Price | $5.99 |
| Market Cap | $84.29M |
| P/E Ratio | 17.65 |
| EPS | $0.34 |
| Dividend Yield | 0.00% |
| 52-Week High | $11.99 |
| 52-Week Low | $3.75 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $56.94M |
| Net Income | $4.70M |
| Gross Margin | 50.15% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $56.94M | $4.70M | $0.34 |
| 2024 | $50.16M | $-7.28M | $-0.54 |
| 2023 | $53.87M | $-5.33M | $-0.39 |
| 2022 | $49.11M | $548.00K | $0.04 |
CSBR analyst coverage data. Average price target: $0.00.